Neurobiologie der Schizophrenien

• Literatur

• Bogerts B. Neurobiologie psychischer Störungen: schizophrene Störungen. In: Gruender G, Holsboer F, Benkert O, Hrsg Handbuch der Psychopharmakotherapie.. Heidelberg, Springer-Verlag: 2008: 260-273
• Bleuler E. Dementia praecox oder die Gruppe der Schizophrenien. In: Aschaffenburg G, Hrsg Handbuch der Psychiatrie.. Leipzig, Wien, Deuticke: 1911
• Nickl-Jockschat T, Rietschel M, Kircher T. Korrelation zwischen Risikogenvarianten für Schizophrenie und Hirnstrukturanomalien.. Nervenarzt 2009; 80: 40-53
• Bogerts B. Funktionell-neuroanatomische und neuropathologische Grundlagen psychischer Störungen. In: Möller H, Laux G, Kapfhammer HP, Hrsg Psychiatrie und Psychotherapie.. Heidelberg, Springer-Verlag: 2008: 110-127
• Huber G. Chronische Schizophrenie, Synopsis klinischer und neuroradiologischer Untersuchungen.. Heidelberg: Hütig-Verlag 1961
• Lieberman J, Bogerts B, Degreef G. et al. Qualitative assessment of brain morphology in acute and chronic schizophrenia.. Am J Psychiatry 1992; 149: 784-794
• Segall JM, Turner JA, van Erp TG. et al. Voxel-based morphometric multisite collaborative study on schizophrenia.. Schizophr Bull 2009; 35: 82-95
• Schlaepfer TE, Harris GJ, Tien AY. et al. Decreased regional cortical gray matter volume in schizophrenia.. Am J Psychiatry 1994; 151: 842-848
• Degreef G, Ashtari M, Bogerts B. et al. Volumes of ventricular system subdivisions measured from magnetic resonance images in first-episode schizophrenic patients.. Arch Gen Psychiatry 1992; 49: 531-537
• Lui S, Deng W, Huang X. et al. Association of cerebral deficits with clinical symptoms in antipsychotic-naive first-episode schizophrenia: an optimized voxel-based morphometry and resting state functional connectivity study.. Am J Psychiatry 2009; 166: 196-205
• Bogerts B, Meertz E, Schonfeldt-Bausch R. Basal ganglia and limbic system pathology in schizophrenia. A morphometric study of brain volume and shrinkage.. Arch Gen Psychiatry 1985; 42: 784-791
• Selemon LD, Goldman-Rakic PS. The reduced neuropil hypothesis: a circuit based model of schizophrenia.. Biol Psychiatry 1999; 45: 17-25
• Danos P. Pathologie des Thalamus und der Schizophrenie.. Fortschr Neurol Psychiatr 2004; 72: 621-634
• Falkai P, Honer WG, David S. et al. No evidence for astrogliosis in brains of schizophrenic patients. A post-mortem study.. Neuropathol Appl Neurobiol 1999; 25: 48-53
• Bogerts B, Steiner J, Bernstein HG. Brain abnormalities in Schizophrenia. In: Kasper S, Papadimitriou GN, eds Schizophrenia. 2. Auflage ed.. New York, Informa Healthcare: 2009
• Sawada K, Barr AM, Nakamura M. et al. Hippocampal complexin proteins and cognitive dysfunction in schizophrenia.. Arch Gen Psychiatry 2005; 62: 263-272
• Harrison PJ, Law AJ. Neuregulin 1 and schizophrenia: genetics, gene expression, and neurobiology.. Biol Psychiatry 2006; 60: 132-140
• Black JE, Kodish IM, Grossman AW. et al. Pathology of layer V pyramidal neurons in the prefrontal cortex of patients with schizophrenia.. Am J Psychiatry 2004; 161: 742-744
• Stephan KE, Baldeweg T, Friston KJ. Synaptic plasticity and dysconnection in schizophrenia.. Biol Psychiatry 2006; 59: 929-939
• Smalla KH, Mikhaylova M, Sahin J. et al. A comparison of the synaptic proteome in human chronic schizophrenia and rat ketamine psychosis suggest that prohibitin is involved in the synaptic pathology of schizophrenia.. Mol Psychiatry 2008; 13: 878-896
• Buchsbaum MS, Friedman J, Buchsbaum BR. et al. Diffusion tensor imaging in schizophrenia.. Biol Psychiatry 2006; 60: 1181-1187
• Shergill SS, Kanaan RA, Chitnis XA. et al. A diffusion tensor imaging study of fasciculi in schizophrenia.. Am J Psychiatry 2007; 164: 467-473
• Kanaan R, Barker G, Brammer M. et al. White matter microstructure in schizophrenia: effects of disorder, duration and medication.. Br J Psychiatry 2009; 194: 236-242
• Tkachev D, Mimmack ML, Huffaker SJ. et al. Further evidence for altered myelin biosynthesis and glutamatergic dysfunction in schizophrenia.. Int J Neuropsychopharmacol 2007; 10: 1-7
• Rajkowska G, Miguel-Hidalgo JJ, Makkos Z. et al. Layer-specific reductions in GFAP-reactive astroglia in the dorsolateral prefrontal cortex in schizophrenia.. Schizophr Res 2002; 57: 127-138
• Kolomeets NS. Astroglia of the hippocampus in schizophrenia.. Zh Nevrol Psikhiatr Im S S Korsakova 2008; 108: 70-76
• Steffek AE, McCullumsmith RE, Haroutunian V. et al. Cortical expression of glial fibrillary acidic protein and glutamine synthetase is decreased in schizophrenia.. Schizophr Res 2008; 103: 71-82
• Steiner J, Bernstein HG, Bielau H. et al. S100B-immunopositive glia is elevated in paranoid as compared to residual schizophrenia: a morphometric study.. J Psychiatr Res 2008; 42: 868-876
• Uranova NA, Orlovskaia DD, Vikhreva OV. et al. Morphometric study of ultrastructural changes in oligodendroglial cells in the postmortem brain in endogenous psychoses.. Vestn Ross Akad Med Nauk 2001; 7: 42-48
• Hof PR, Haroutunian V, Copland C. et al. Molecular and cellular evidence for an oligodendrocyte abnormality in schizophrenia.. Neurochem Res 2002; 27: 1193-1200
• Bahn S, Mimmack M, Ryan M. et al. Neuronal target genes of the neuron-restrictive silencer factor in neurospheres derived from fetuses with Down's syndrome: a gene expression study.. Lancet 2002; 359: 310-315
• Uranova NA, Vostrikov VM, Vikhreva OV. et al. The role of oligodendrocyte pathology in schizophrenia.. Int J Neuropsychopharmacol 2007; 10: 537-545
• Schmitt A, Steyskal C, Bernstein HG. et al. Stereologic investigation of the posterior part of the hippocampus in schizophrenia.. Acta Neuropathol 2008; 117: 395-407
• Mitkus SN, Hyde TM, Vakkalanka R. et al. Expression of oligodendrocyte-associated genes in dorsolateral prefrontal cortex of patients with schizophrenia.. Schizophr Res 2008; 98: 129-138
• Schroeter ML, Steiner J. Elevated serum levels of the glial marker protein S100B are not specific for schizophrenia or mood disorders.. Mol Psychiatry 2009; 14: 235-237
• Steiner J, Bernstein HG, Bogerts B. et al. S100B is expressed in, and released from, OLN-93 oligodendrocytes: Influence of serum and glucose deprivation.. Neuroscience 2008; 154: 496-503
• Stefansson H, Sarginson J, Kong A. et al. Association of neuregulin 1 with schizophrenia confirmed in a Scottish population.. Am J Hum Genet 2003; 72: 83-87
• Bertram I, Bernstein HG, Lendeckel U. et al. Immunohistochemical evidence for impaired neuregulin-1 signaling in the prefrontal cortex in schizophrenia and in unipolar depression.. Ann N Y Acad Sci 2007; 1096: 147-156
• Addington AM, Gornick MC, Shaw P. et al. Neuregulin 1 (8p12) and childhood-onset schizophrenia: susceptibility haplotypes for diagnosis and brain developmental trajectories.. Mol Psychiatry 2007; 12: 195-205
• Weickert CS, Straub RE, McClintock BW. et al. Human dysbindin (DTNBP1) gene expression in normal brain and in schizophrenic prefrontal cortex and midbrain.. Arch Gen Psychiatry 2004; 61: 544-555
• Camargo LM, Collura V, Rain JC. et al. Disrupted in Schizophrenia 1 Interactome: evidence for the close connectivity of risk genes and a potential synaptic basis for schizophrenia.. Mol Psychiatry 2007; 12: 74-86
• Callicott JH, Straub RE, Pezawas L. et al. Variation in DISC1 affects hippocampal structure and function and increases risk for schizophrenia.. Proc Natl Acad Sci U S A 2005; 102: 8627-8632
• Fan JB, Zhang CS, Gu NF. et al. Catechol-O-methyltransferase gene Val / Met functional polymorphism and risk of schizophrenia: a large-scale association study plus meta-analysis.. Biol Psychiatry 2005; 57: 139-144
• Egan MF, Goldberg TE, Kolachana BS. et al. Effect of COMT Val108 / 158 Met genotype on frontal lobe function and risk for schizophrenia.. Proc Natl Acad Sci U S A 2001; 98: 6917-6922
• Brisch R, Bernstein HG, Krell D. et al. Dopamine-glutamate abnormalities in the frontal cortex associated with the Catechol-O-Methyltransferase (COMT) in schizophrenia.. Brain Res 2009; 1269: 166-175
• Mössner R, Schuhmacher A, Schulze-Rauschenbach S. et al. Further evidence for a functional role of the glutamate receptor gene GRM3 in schizophrenia.. Eur Neuropsychopharmacol 2008; 18: 768-772
• Mössner R, Maier W, Rujescu D. Neue Erkenntnisse zur Genetik der Schizophrenie.. Nervenarzt 2009; 80: 6-11
• Kristiansen LV, Huerta I, Beneyto M. et al. NMDA receptors and schizophrenia.. Curr Opin Pharmacol 2007; 7: 48-55
• Jakob H, Beckmann H. Prenatal developmental disturbances in the limbic allocortex in schizophrenics.. J Neural Transm 1986; 65: 303-326
• Arnold SE, Hyman BT, van Hoesen GW. et al. Some cytoarchitectural abnormalities of the entorhinal cortex in schizophrenia.. Arch Gen Psychiatry 1991; 48: 625-632
• Falkai P, Schneider T, Greve B. et al. Reduced frontal and occipital lobe asymmetry on the CT-scans of schizophrenic patients. Its specificity and clinical significance.. J Neural Transm 1995; 99: 63-77
• Vogeley K, Schneider-Axmann T, Pfeiffer U. et al. Disturbed gyrification of the prefrontal region in male schizophrenic patients: A morphometric postmortem study.. Am J Psychiatry 2000; 157: 34-39
• van Haren NE, Hulshoff Pol HE, Schnack HG. et al. Progressive brain volume loss in schizophrenia over the course of the illness: evidence of maturational abnormalities in early adulthood.. Biol Psychiatry 2008; 63: 106-113
• Narayan S, Tang B, Head SR. et al. Molecular profiles of schizophrenia in the CNS at different stages of illness.. Brain Res 2008, online 0
• Wagner-Jauregg J. Über die Einwirkung fieberhafter Erkrankungen auf Psychosen.. Allgemeine Zeitschrift für Psychiatrie 1887; 27: 93-131
• Nunes SO, Borelli SD, Matsuo T. et al. The association of the HLA in patients with schizophrenia, schizoaffective disorder, and in their biological relatives.. Schizophr Res 2005; 76: 195-198
• Fan X, Pristach C, Liu EY. et al. Elevated serum levels of C-reactive protein are associated with more severe psychopathology in a subgroup of patients with schizophrenia.. Psychiatry Res 2007; 149: 267-271
• Sperner-Unterweger B. Immunological aetiology of major psychiatric disorders: evidence and therapeutic implications.. Drugs 2005; 65: 1493-1520
• Potvin S, Stip E, Sepehry AA. et al. Inflammatory Cytokine Alterations in Schizophrenia: A Systematic Quantitative Review.. Biol Psychiatry 2008; 63: 801-808
• Riedel M, Spellmann I, Schwarz MJ. et al. Decreased T cellular immune response in schizophrenic patients.. J Psychiatr Res 2007; 41: 3-7
• Müller N, Schwarz MJ. Neuroimmune-endocrine crosstalk in schizophrenia and mood disorders.. Expert Rev Neurother 2006; 6: 1017-1038
• Torrey EF, Leweke MF, Schwarz MJ. et al. Cytomegalovirus and schizophrenia.. CNS Drugs 2006; 20: 879-885
• Brown AS. The risk for schizophrenia from childhood and adult infections.. Am J Psychiatry 2008; 165: 7-10
• Torrey EF, Bartko JJ, Lun ZR. et al. Antibodies to Toxoplasma gondii in patients with schizophrenia: a meta-analysis.. Schizophr Bull 2007; 33: 729-736
• Schwarcz R, Hunter CA. Toxoplasma gondii and schizophrenia: linkage through astrocyte-derived kynurenic acid?. Schizophr Bull 2007; 33: 652-653
• Bayer TA, Buslei R, Havas L. et al. Evidence for activation of microglia in patients with psychiatric illnesses.. Neurosci Lett 1999; 271: 126-128
• Radewicz K, Garey LJ, Gentleman SM. et al. Increase in HLA-DR immunoreactive microglia in frontal and temporal cortex of chronic schizophrenics.. J Neuropathol Exp Neurol 2000; 59: 137-150
• Steiner J, Bielau H, Brisch R. et al. Immunological aspects in the neurobiology of suicide: Elevated microglial density in schizophrenia and depression is associated with suicide.. J Psychiatr Res 2008; 42: 151-157
• Steiner J, Mawrin C, Ziegeler A. et al. Distribution of HLA-DR-positive microglia in schizophrenia reflects impaired cerebral lateralization.. Acta Neuropathol 2006; 112: 305-316
• Newcomer JW. Antipsychotic medications: metabolic and cardiovascular risk.. J Clin Psychiatry 2007; 68 (Suppl. 4): 8-13
• Gough SC, O'Donovan MC. Clustering of metabolic comorbidity in schizophrenia: a genetic contribution?. J Psychopharmacol 2005; 19: 47-55
• Mukherjee S, Decina P, Bocola V. et al. Diabetes mellitus in schizophrenic patients.. Compr Psychiatry 1996; 37: 68-73
• Thakore JH. Metabolic syndrome and schizophrenia.. Br J Psychiatry 2005; 186: 455-456
• Fernandez-Egea E, Bernardo M, Parellada E. et al. Glucose abnormalities in the siblings of people with schizophrenia.. Schizophr Res 2008; 103: 110-113
• Frölich L, Blum-Degen D, Bernstein HG. et al. Brain insulin and insulin receptors in aging and sporadic Alzheimer's disease.. J Neural Transm 1998; 105: 423-438
• Bruning JC, Gautam D, Burks DJ. et al. Role of brain insulin receptor in control of body weight and reproduction.. Science 2000; 289: 2122-2125
• Huang JT, Leweke FM, Tsang TM. et al. CSF metabolic and proteomic profiles in patients prodromal for psychosis.. PLoS ONE 2007; 2: e756
• Zhao Z, Ksiezak-Reding H, Riggio S. et al. Insulin receptor deficits in schizophrenia and in cellular and animal models of insulin receptor dysfunction.. Schizophr Res 2006; 84: 1-14
• Fan X, Liu E, Pristach C. et al. Higher fasting serum insulin levels are associated with a better psychopathology profile in acutely ill non-diabetic inpatients with schizophrenia.. Schizophr Res 2006; 86: 30-35
• Buchsbaum MS, Buchsbaum BR, Hazlett EA. et al. Relative glucose metabolic rate higher in white matter in patients with schizophrenia.. Am J Psychiatry 2007; 164: 1072-1081
• Peters A, Pellerin L, Dallman MF. et al. Causes of obesity: looking beyond the hypothalamus.. Prog Neurobiol 2007; 81: 61-88
• Edlinger M, Ebenbichler C, Rettenbacher M. et al. Treatment of antipsychotic-associated hyperglycemia with pioglitazone: a case series.. J Clin Psychopharmacol 2007; 27: 403-404
• Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes.. J Clin Invest 2005; 115: 1111-1119
• Fan X, Goff DC, Henderson DC. Inflammation and schizophrenia.. Expert Rev Neurother 2007; 7: 789-796